Preservation of Access for Seniors in Medicare Advantage Act of 2015
Do you support it?
Want to know if it passes?
We'll email you when HR 2581 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HR 2581.
You're tracking HR 2581
We'll email you the moment it moves.
HR 2581 — Preservation of Access for Seniors in Medicare Advantage Act of 2015
Last action — Placed on the Union Calendar, Calendar No. 117.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
Died in session
This bill died with 114th Congress. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Preservation of Access for Seniors in Medicare Advantage Act of 2015 (Sec. 2) This bill requires the Department of Health and Human Services (HHS) to establish a three-year demonstration program (extendable if necessary to four or five years) to test the use of value-based insurance design methodologies under the eligible Medicare Advantage (MA) plans offered by MA organizations under part C (Medicare+Choice Program) of title XVIII (Medicare) of the Social Security Act (SSAct). "Value-based insurance design methodology" is one for identifying specific prescription medications, and clinical services payable under Medicare, for which copayments, coinsurance, or both would improve the management of specific chronic clinical conditions because of the high value and effectiveness of such medications and services for such specific chronic clinical conditions, as approved by HHS. HHS may expand the duration and scope of the demonstration program to an appropriate extent if specified requirements are met. (Sec. 3) The annual 45-day period for disenrollment from MA plans to elect to receive benefits under the original Medicare fee-for-service program, and to elect coverage under part D (Voluntary Prescription Drug Benefit Program), shall end on December 31, 2015. Starting in 2016, a Medicare Advantage eligible individual, during the first three months of any year, may change a previous election to elect to receive benefits through the original Medicare fee-for-service program or an MA plan, and to elect coverage under part D. This continuous open enrollment and disenrollment period during the first three months of any year starting in 2016 shall apply with respect to a prescription drug plan only in the case of an individual who, previous to such change in enrollment, is enrolled in a MA plan. No unsolicited marketing or marketing materials may be sent to such an eligible individual during the continuous open enrollment and disenrollment period. (Sec. 4) This bill also amends part B (Supplementary Medical Insurance) of SSAct title XVIII to revise requirements (in effect, changing payment methodologies from 95% of the Average Wholesale Price to the Average Sales Price plus six) for payments for infusion drugs and biologicals furnished through durable medical equipment on or after January 1, 2017. (Sec. 5) It is the sense of Congress that HHS: has incorrectly interpreted the determination of blended benchmark amounts as prohibiting any Medicare quality incentive payments with respect to MA plans that exceed the payment benchmark cap for the area served by those plans; and should immediately apply quality incentive payments with respect to such MA plans without regard to specified limits.
Bill Text
We don't have the full text on file for this bill yet.
Read HR 2581 on the official United States source →Action History
-
Placed on the Union Calendar, Calendar No. 117.
-
Committee on Energy and Commerce discharged.
-
Reported (Amended) by the Committee on Ways and Means. H. Rept. 114-161, Part I.
-
Referred to the Subcommittee on Health.
-
Referred to the Subcommittee on Health.
-
Ordered to be Reported (Amended) by Voice Vote.
-
Committee Consideration and Mark-up Session Held.
-
Referred to House Energy and Commerce
-
Referred to House Ways and Means
-
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
-
Introduced in House
Sponsors
- Kevin Brady · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 546 not signed on
Sponsors (1)
Co-sponsors (0)
None.
Not signed on (546)
546 members have not signed on to this bill.
Show all 546 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HR 2581 do?
- Preservation of Access for Seniors in Medicare Advantage Act of 2015 (Sec. 2) This bill requires the Department of Health and Human Services (HHS) to establish a three-year demonstration program (extendable if necessary to four or five years) to test the use of value-based insurance design methodologies under the eligible Medicare Advantage (MA) plans offered by MA organizations under part C (Medicare+Choice Program) of title XVIII (Medicare) of the Social Security Act (SSAct). "Value-based insurance design methodology" is one for identifying specific prescription medications, and clinical services payable under Medicare, for which copayments, coinsurance, or both would improve the management of specific chronic clinical conditions because of the high value and effectiveness of such medications and services for such specific chronic clinical conditions, as approved by HHS. HHS may expand the duration and scope of the demonstration program to an appropriate extent if specified requirements are met. (Sec. 3) The annual 45-day period for disenrollment from MA plans to elect to receive benefits under the original Medicare fee-for-service program, and to elect coverage under part D (Voluntary Prescription Drug Benefit Program), shall end on December 31, 2015. Starting in 2016, a Medicare Advantage eligible individual, during the first three months of any year, may change a previous election to elect to receive benefits through the original Medicare fee-for-service program or an MA plan, and to elect coverage under part D. This continuous open enrollment and disenrollment period during the first three months of any year starting in 2016 shall apply with respect to a prescription drug plan only in the case of an individual who, previous to such change in enrollment, is enrolled in a MA plan. No unsolicited marketing or marketing materials may be sent to such an eligible individual during the continuous open enrollment and disenrollment period. (Sec. 4) This bill also amends part B (Supplementary Medical Insurance) of SSAct title XVIII to revise requirements (in effect, changing payment methodologies from 95% of the Average Wholesale Price to the Average Sales Price plus six) for payments for infusion drugs and biologicals furnished through durable medical equipment on or after January 1, 2017. (Sec. 5) It is the sense of Congress that HHS: has incorrectly interpreted the determination of blended benchmark amounts as prohibiting any Medicare quality incentive payments with respect to MA plans that exceed the payment benchmark cap for the area served by those plans; and should immediately apply quality incentive payments with respect to such MA plans without regard to specified limits.
- Who sponsors HR 2581?
- HR 2581 is sponsored by Kevin Brady (R).
- What is the current status of HR 2581?
- This bill died with 114th Congress. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track HR 2581?
- Track HR 2581 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HR 2581
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HR 2581
Last checked for changes about 9 hours ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →